Member Info for Let-It-Roll

Here we go.....

:-)

The short answer is unfortunately no there is nothing you can do. You should never invest more than what you can afford to loose. That is true on any stock.

Having said that.. I do not think you need to worry any more. £15 is easily achievable as fair value at the moment would be a MCAP of £100m which is £18-£20 per share. So within a matter of weeks you will find yourself in profit.

As BBB11 already said:

Check the off-market delayed trades:

£100k (Wed)

£215k (Thu)

£260k (Fri)

= £575k total.

All placed at the same price, spread across time, all off-market with a delay... classic institutional accumulation? (Fingers crossed)

With HEMO up nearly 200% last week, this looks like a big investor or whale building a position quietly to avoid spiking the spread. If this continues... we are in for a great week. GLA

Interesting the data they will already have now on efficacy:

Outcome Measure Measure Description Time Frame

Estimate the efficacy of HG-CT-1 cells as defined by clinical response according to established criteria for AML. Proportion of subjects with response, according to ELN 2022 criteria. {Dohner et al., 2022 #29518}. To demonstrate the anti-AML activity of HG-CT-1. Day 14, Day 28, Month 3, Month 6 and Month 12

Estimate the Overall Survival (OS). Proportion of subjects alive at 6 months and one year. To demonstrate effect on disease biology and prognosis (compared to historical expectations). At 6 months and 1 year

Estimate the progression-free survival (PFS). Proportion of subjects alive without progression at 6 months and one year. To demonstrate durability of anti-AML effect. At 6 months and 1 year

Estimate the Duration of response (DOR). Proportion of subjects with response who remain alive and without progression at 6 months and at one year. To demonstrate durability of anti-AML effect. At 6 months and 1 year

Know this board love a bit of speculation... So where do you reckon the SP is going to be by the end of Monday?

With or without an RNS.

I'm going with £8.

As has been said in a number of places now, and also by myself, the fair MCAP for Hemo with just its CAR-T is £100m. which equates to a share price of circa £18.00-£20.00

Even if we are more conservative and halve that, we're still looking at a share price of £9-£10

And we closed at £5.14

It's not rocket science to see where this is going. And that's without any positive RNS in the mix over patients 1-3 or 1st child.

Off... have you not been paying attention??

Will go back up, now the MM's have got a few shares

It's here.

There is so little stock available. Constantly going into auction now.

As Subush and others have already said: £100m MCAP is fair value for just HEMO CAR-T. That's a SP of around £18.

That's where we're heading.

There is so little stock available. Constantly going into auction now.

As Subush and others have already said: £100m MCAP is fair value for just HEMO CAR-T. That's a SP of around £18.

That's where we're heading.

100 MCAP so around a SP of £18 is fair market value for just Hemo CAR-T

This correction is soo long overdue. And easy 2x or 3x from here too.

In auction.

Just Housekeeping. Lol.

There are no words to add. You've said it so well.

Simply priceless.

Doesn't stop you being a conplete t*sser tho does it.

Attention seeker. Nothing more. Nothing less. No life or social skills.

Pretty sure Aldermoron is @WoodyHodl on Twitter/X

Monday or Tuesday RNS's are better than Fridsy ones imo... but then again..positive news is positive news!